Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study

Clinical Endocrinology

Volumn 81, Issue 1, 2014, Pages 52-57

  Hosseinpanah, Farhad ^a   Barzin, Maryam ^a   Erfani, Hadi ^b   Serahati, Sara ^a   Ramezani Tehrani, Fahimeh ^b   Azizi, Fereidoun ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; IRAN; LIPID ACCUMULATION PRODUCT INDEX; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE; WAIST HIP RATIO; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; IRAN; LIPID ACCUMULATION PRODUCT; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 84902550104     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12287     Document Type: Article

References (32)

1. Asuncion, M., Calvo, R.M., San Millan, J.L., et al,. (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. The Journal of Clinical Endocrinology and Metabolism, 85, 2434-2438.
2. Wiltgen, D., Benedetto, I.G., Mastella, L.S., et al,. (2009) Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Human Reproduction, 24, 1726-1731.
3. Diamanti-Kandarakis, E., Kouli, C.R., Bergiele, A.T., et al,. (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. The Journal of Clinical Endocrinology and Metabolism, 84, 4006-4011.
4. Coviello, A.D., Legro, R.S., &, Dunaif, A., (2006) Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. The Journal of Clinical Endocrinology and Metabolism, 91, 492-497.
5. Moran, L., &, Teede, H., (2009) Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Human Reproduction Update, 15, 477-488.
6. Salley, K.E., Wickham, E.P., Cheang, K.I., et al,. (2007) Glucose intolerance in polycystic ovary syndrome-a position statement of the Androgen Excess Society. The Journal of Clinical Endocrinology and Metabolism, 92, 4546-4556.
7. Orio, F., Palomba, S., &, Colao, A., (2006) Cardiovascular risk in women with polycystic ovary syndrome. Fertility and Sterility, 86 (Suppl 1), S20-S21.
8. Palomba, S., Falbo, A., Russo, T., et al,. (2007) Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, 92, 3128-3135.
9. Kahn, H.S., (2005) The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovascular Disorders, 5, 26.
10. Tehrani, F.R., Simbar, M., Tohidi, M., et al,. (2011) The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reproductive Biology and Endocrinology: RB&E, 9, 39.
11. Alberti, K.G., Eckel, R.H., Grundy, S.M., et al,. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120, 1640-1645.
12. Delavari, A., Forouzanfar, M.H., Alikhani, S., et al,. (2009) First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care, 32, 1092-1097.
13. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 81, 19-25.
14. Chiazze, L. Jr., Brayer F.T., Macisco, J.J. Jr., et al,. (1968) The length and variability of the human menstrual cycle. JAMA: The Journal of the American Medical Association, 203, 377-380.
15. Hatch, R., Rosenfield, R.L., Kim, M.H., et al,. (1981) Hirsutism: implications, etiology, and management. American Journal of Obstetrics and Gynecology, 140, 815-830.
16. Jonard, S., Robert, Y., Cortet-Rudelli, C., et al,. (2003) Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Human Reproduction, 18, 598-603.
17. Wallace, T.M., Levy, J.C., &, Matthews, D.R., (2004) Use and abuse of HOMA modeling. Diabetes Care, 27, 1487-1495.
18. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital and health statistics Ser 1, Programs and collection procedures. 1994: 1-407.
19. Akobeng, A.K., (2007) Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatrica, 96, 644-647.
20. Kahn, H.S., (2006) The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care, 29, 151-153.
21. Ioachimescu, A.G., Brennan, D.M., Hoar, B.M., et al,. (2010) The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity (Silver Spring), 18, 1836-1844.
22. Bozorgmanesh, M., Hadaegh, F., &, Azizi, F., (2010) Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study. Lipids in Health and Disease, 9, 100.
23. Taverna, M.J., Martinez-Larrad, M.T., Frechtel, G.D., et al,. (2011) Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. European journal of endocrinology/European Federation of Endocrine Societies, 164, 559-567.
24. Bozorgmanesh, M., Hadaegh, F., &, Azizi, F., (2010) Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids in Health and Disease, 9, 45.
25. Olefsky, J., Farquhar, J.W., &, Reaven, G., (1973) Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes, 22, 507-513.
26. Chevenne, D., Trivin, F., &, Porquet, D., (1999) Insulin assays and reference values. Diabetes & Metabolism, 25, 459-476.
27. Wehr, E., Gruber, H.J., Giuliani, A., et al,. (2011) The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. The Journal of Clinical Endocrinology and Metabolism, 96, E986-E990.
28. Luo, X.Y., &, Xu, L.Z., (2012) [Association of fat distribution with metabolic syndrome in patients with polycystic ovary syndrome]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 32, 1325-1327.
29. Costa, E.C., Sa, J.C., Soares, E.M., et al,. [Evaluation of cardiovascular risk by the LAP index in non-obese patients with polycystic ovary syndrome]. Arquivos Brasileiros de Endocrinologia e Metabologia. 2010; 54: 630-635. Avaliacao do risco cardiovascular por meio do indice LAP em pacientes nao obesas com sindrome dos ovarios policisticos.
30. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al,. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
31. Skrha, J., Haas, T., Sindelka, G., et al,. (2004) Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders. The Journal of Clinical Endocrinology and Metabolism, 89, 135-141.
32. Lawson, M.A., Jain, S., Sun, S., et al,. (2008) Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women. The Journal of Clinical Endocrinology and Metabolism, 93, 2089-2096.